Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Rengcheng Qian"'
Autor:
Rengcheng Qian, Huihui Chen, Hongzhou Lin, Yalan Jiang, Pingping He, Yinjuan Ding, Huilan Wu, Yongmiao Peng, Lingfei Wang, Congde Chen, Dexuan Wang, Weiping Ji, Xiaoling Guo, Xiaoou Shan
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Background: Type 1 diabetes mellitus (T1DM) is one of the most common endocrine and metabolic diseases in children. Pancreatic β cells are thought to be critical cells involved in the progression of T1DM, and their injury would directly lead to impa
Externí odkaz:
https://doaj.org/article/d14794204f02475ebaa308f617a5d71f
Autor:
Xiaoling Guo, Rengcheng Qian, Liang Yang, Huihui Chen, Yinjuan Ding, Xiaoou Shan, Congde Chen, Wenfei Ni, Jian Lin, Maoping Chu
Publikováno v:
Stem Cell Research, Vol 53, Iss , Pp 102281- (2021)
Noonan Syndrome (NS) is an inherited autosome dominant disorder syndrome, which can be caused by the mutations of serine/threonine kinase rapidly accelerated fibrosarcoma 1 (RAF1) gene. Here, an induced pluripotent stem cell (iPSC) line named WMUi022
Externí odkaz:
https://doaj.org/article/6dbaba2a876444f1a15a03c27b9158a6
Publikováno v:
Translational Cancer Research. 11:1938-1953
Peroxisome proliferator-activated receptor gamma (PPARG) plays some roles in preventing liver disease progression to hepatocellular carcinoma. However, there is limited information about the function of PPARG of in hepatocellular carcinoma. This stud
Autor:
Hongzhou Lin, Huihui Chen, Rengcheng Qian, Guoqi Tang, Yinjuan Ding, Yalan Jiang, Congde Chen, Dexuan Wang, Maoping Chu, Xiaoling Guo
Publikováno v:
Chemico-Biological Interactions. :110559
Autor:
Congde Chen, Liang Yang, Yinjuan Ding, Rengcheng Qian, Maoping Chu, Jian Lin, Xiaoling Guo, Wenfei Ni, Xiaoou Shan, Huihui Chen
Publikováno v:
Stem Cell Research, Vol 53, Iss, Pp 102281-(2021)
Noonan Syndrome (NS) is an inherited autosome dominant disorder syndrome, which can be caused by the mutations of serine/threonine kinase rapidly accelerated fibrosarcoma 1 (RAF1) gene. Here, an induced pluripotent stem cell (iPSC) line named WMUi022